We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+2.52%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$3.13B
AUM Growth
+$2.05M
Cap. Flow
-$6.64M
Cap. Flow %
-0.21%
Top 10 Hldgs %
61.22%
Holding
455
New
15
Increased
222
Reduced
42
Closed
19

Top Sells

Rank Stock Value
1
MDB icon
MongoDB
MDB
+$26M
2
COHR icon
Coherent
COHR
+$23.8M
3
PYPL icon
PayPal
PYPL
+$19.4M
4
BSX icon
Boston Scientific
BSX
+$14.3M
5
MSGS icon
Madison Square Garden
MSGS
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 42.95%
2 Technology 8.58%
3 Utilities 8.35%
4 Energy 7.73%
5 Communication Services 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
401
Alibaba
BABA
$293B
$11K ﹤0.01%
100
-105,200
-100% -$12.1M
INTU icon
402
Intuit
INTU
$86.5B
$11K ﹤0.01%
23
OMCL icon
403
Omnicell
OMCL
$1.61B
$11K ﹤0.01%
85
HUBS icon
404
HubSpot
HUBS
$12.2B
$10K ﹤0.01%
22
EWJ icon
405
iShares MSCI Japan ETF
EWJ
$21.9B
$8K ﹤0.01%
125
FPI
406
Farmland Partners
FPI
$408M
$8K ﹤0.01%
576
OXY.WS icon
407
Occidental Petroleum Corp Warrants
OXY.WS
$33B
$8K ﹤0.01%
216
SLNO
408
DELISTED
Soleno Therapeutics
SLNO
$8K ﹤0.01%
2,288
LAB icon
409
Standard BioTools
LAB
$340M
$7K ﹤0.01%
1,975
SGMO
410
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$7K ﹤0.01%
1,273
SIEN
411
DELISTED
Sientra, Inc.
SIEN
$7K ﹤0.01%
308
JNCE
412
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$7K ﹤0.01%
1,009
CDTX
413
DELISTED
Cidara Therapeutics
CDTX
$6K ﹤0.01%
387
HPQ icon
414
HP
HPQ
$24.9B
$6K ﹤0.01%
172
+1
+0.6% +$37
MYO icon
415
Myomo
MYO
$39M
$6K ﹤0.01%
1,570
XRX icon
416
Xerox
XRX
$386M
$6K ﹤0.01%
314
+2
+0.6% +$42
PRTK
417
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$6K ﹤0.01%
2,159
ESPR
418
DELISTED
Esperion Therapeutics
ESPR
$5K ﹤0.01%
1,121
OIH icon
419
VanEck Oil Services ETF
OIH
$2.06B
$5K ﹤0.01%
16
HPE icon
420
Hewlett Packard
HPE
$63.4B
$3K ﹤0.01%
166
+1
+0.6% +$17
ETTX
421
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$3K ﹤0.01%
1,448
CTMX icon
422
CytomX Therapeutics
CTMX
$675M
$2K ﹤0.01%
712
KD icon
423
Kyndryl
KD
$2.99B
$2K ﹤0.01%
160
KRRO icon
424
Korro Bio
KRRO
$150M
$2K ﹤0.01%
22
WAB icon
425
Wabtec
WAB
$49.1B
$2K ﹤0.01%
21

Similar funds

Bollard Group's Q1 2022 Portfolio in Review

As of Q1 2022, Bollard Group held 455 positions worth $3.13B, up 0.07% from $3.12B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Bollard Group's Q1 2022 filing shows 15 new, 222 increased, 42 reduced and 19 closed positions. Its largest new stake was Guidewire Software: 38,700 shares worth $3.66M. The largest sale was MongoDB, an estimated $26M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 42% a quarter earlier, followed by Technology and Utilities.

  • Bollard Group's largest Q1 2022 buy was Guidewire Software: 38,700 shares worth $3.66M.
  • Bollard Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $50.8M increase.
  • Bollard Group's biggest Q1 2022 reduction was PayPal, cutting an estimated $19.4M.
  • Bollard Group fully exited MongoDB in Q1 2022, selling an estimated $26M.
  • Bollard Group's ten largest holdings make up 61% of its $3.13B portfolio in Q1 2022.
  • Bollard Group opened 15 new positions and closed 19 in Q1 2022.
  • Bollard Group's portfolio value rose 0.07% quarter-over-quarter to $3.13B.

Based on Bollard Group's 13F filing for Q1 2022, filed 12 May 2022.